Education
About Us
Working with TipRanks
Follow Us
Anteris Technologies (AU:AVR)
ASX:AVR
AVR Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.82K
Average Volume (3M)N/A
Market Cap
$341.07M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Anteris Technologies News
PremiumCompany Announcements
Anteris Technologies Files Amendment to Annual Report
PremiumCompany Announcements
Anteris Technologies Announces Cessation of Certain Securities
PremiumCompany Announcements
Anteris Technologies Announces New Securities Quotation
PremiumCompany Announcements
Anteris Technologies Announces Cessation of Securities
PremiumCompany Announcements
Anteris Technologies Reports March 2025 CDI AdjustmentsPremiumCompany Announcements
Anteris Technologies Achieves Milestone with DurAVR® Heart ValvePremiumCompany Announcements
Anteris Technologies Reinforces Commitment to Corporate Governance
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.00%
Mutual Funds
― Other Institutional Investors
99.00% Public Companies and
Individual Investors
AVR FAQ
What was Anteris Technologies’s price range in the past 12 months?
Currently, no data Available
What is Anteris Technologies’s market cap?
Anteris Technologies’s market cap is $341.07M.
When is Anteris Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anteris Technologies’s earnings last quarter?
Currently, no data Available
Is Anteris Technologies overvalued?
According to Wall Street analysts Anteris Technologies’s price is currently Overvalued.
Does Anteris Technologies pay dividends?
Anteris Technologies does not currently pay dividends.
What is Anteris Technologies’s EPS estimate?
Anteris Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anteris Technologies have?
Currently, no data Available
What happened to Anteris Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Anteris Technologies?
Currently, no hedge funds are holding shares in AU:AVR
---
Anteris Technologies Stock Smart Score
Company Description
Anteris Technologies
Admedus Ltd is an Australia-based healthcare company which develops, commercializes and distributes next-generation medical technologies and devices. It is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The business activity of the company is operated through four segment namely Disposable medical product and medical devices distribution; Bio implant operations - inclusive of sales, distribution, and manufacturing; Regenerative medicine R&D-ADAPT technology, and Immunotherapies research and development.
---
Technical Analysis
Anteris Technologies
―
Medtronic
―
Boston Scientific
―
Edwards Lifesciences
―
Abbott Laboratories
―
Stryker
―
Zimmer Biomet Holdings
―
---